MedTech Acquisition Statistics Share Statistics MedTech Acquisition has n/a
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding n/a Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 1.25M Failed to Deliver (FTD) Shares 4,970 FTD / Avg. Volume 35.58%
Short Selling Information The latest short interest is 2.85K, so 0.04% of the outstanding
shares have been sold short.
Short Interest 2.85K Short % of Shares Out 0.04% Short % of Float 0.05% Short Ratio (days to cover) 1
Valuation Ratios PE Ratio 0 Forward PE n/a PS Ratio 0 Forward PS n/a PB Ratio 0 P/FCF Ratio 0 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for MedTech Acquisition.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position Current Ratio 0 Quick Ratio 0 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage 11.7
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee n/a Employee Count undefined Asset Turnover 0.45 Inventory Turnover 6.29
Taxes Income Tax -6K Effective Tax Rate 0.02%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is -0.02, so MedTech Acquisition's
price volatility has been lower than the market average.
Beta -0.02 52-Week Price Change n/a 50-Day Moving Average 10.41 200-Day Moving Average 10.22 Relative Strength Index (RSI) 61.46 Average Volume (20 Days) 13,969
Income Statement In the last 12 months, MedTech Acquisition had revenue of 29.43M
and earned -33.23M
in profits. Earnings per share was -1.06.
Revenue 29.43M Gross Profit 25.33M Operating Income -36.16M Net Income -33.23M EBITDA -36.16M EBIT n/a Earnings Per Share (EPS) -1.06
Full Income Statement Balance Sheet Cash & Cash Equivalents n/a Total Debt n/a Net Cash n/a Retained Earnings n/a Total Assets 41.32M Working Capital 28.76M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -40.84M
and capital expenditures 0, giving a free cash flow of -40.84M.
Operating Cash Flow -40.84M Capital Expenditures n/a Free Cash Flow -40.84M FCF Per Share 0
Full Cash Flow Statement Margins Gross margin is 86.06%, with operating and profit margins of -122.88% and -112.92%.
Gross Margin 86.06% Operating Margin -122.88% Pretax Margin -102.07% Profit Margin -112.92% EBITDA Margin -122.88% EBIT Margin -122.88% FCF Margin -138.78%
